Recent Headlines
Within Biotechnology
Bio-Med QC, LLC Announces New Test Procedure to Yield Improved USP Results
Bio-Med QC, LLC announced a new test procedure at the Indian Pharmacists Alliance & Community Pharmacies of Indiana Joint Annual Convention in Indianapolis to improve proficiency test results by an additional 5% when conducting quality system tests of personal aseptic technique. USP Chapter... - April 22, 2010 - Bio-Med QC
Mega Health Camps in Mumbai & Baroda: A Wockhardt Foundation Initiative
On 18th April 2010 a Mega Diabetes Camp was held by Wockhardt Foundation in Baroda, Gujarat & simultaneously another medical camp was held at Worli, Mumbai on the same day. - April 22, 2010 - Wockhardt Foundation
Prof. Joseph Paulauskis Joins the Scientific Advisory Board at Ocimum-Genelogic
Prof. Joseph Paulauskis from the International Genomics Consortium has joined the ocimum’s Scientific Advisory Board. Prof. Paulauskis was associated with research and development and also led management of external collaborations for Pfizer Inc. - April 22, 2010 - ocimum biosolutions
Colorado BioScience Association Announces 2010 Sponsors and Appoints Nine New Board Members
The Colorado BioScience Association (CBSA) announced 2010 association sponsors and welcomed nine new directors at its 2010 Annual All-Member Meeting held at the Colorado National Golf Club facilities in Erie, CO. The agenda also included presentations about the newly formed Colorado Institute for Drug, Device and Diagnostic Development (CID4) and Colorado Center for Drug Discovery (C2D2). - April 21, 2010 - Colorado BioScience Association
1 Lakh Patients in First 100 days: A Breakthrough by Wockhardt Foundation
After successfully examining 100,000 patients by the first quarter of 2010, which was the total of last year’s achievement. Wockhardt Foundation is fully geared up for more, and this indeed is a remarkable achievement, by the Mobile Medical Unit. - April 21, 2010 - Wockhardt Foundation
Health Decisions Expands the Agile Clinical Network with the Addition of African CRO ClinResearch
International research network’s continued growth strengthens its aim to raise standards of efficiency and quality for global clinical trials. - April 15, 2010 - Health Decisions
International Stem Cell Corporation Provides Strategic Update on Its Skin Care Program
International Stem Cell Corporation (ISCO.OB), announced that its wholly owned subsidiary, Lifeline Skin Care Inc., has achieved positive results in human safety tests of its cosmetic products and is moving forward with arrangements with Cosmetic Enterprises Ltd. for the manufacture of three... - April 11, 2010 - International Stem Cell Corporation
Wockhardt Foundation Collaborates with AmeriCares India for a Noble Cause on World Health Day
A mega health check up camp was conducted by Wockhardt Foundation and AmeriCares India on 7th April 2010, ‘World Health Day’, in remote interiors of Kalyan, as an initiative by the leading healthcare NGOs to make cities healthier. The camp kick started at 8.30 am, wherein a thorough... - April 10, 2010 - Wockhardt Foundation
Dr. Chang-Hwan Choi Honored with Prestigious Young Investigator Award
Professor Chang-Hwan Choi of the Department of Mechanical Engineering at Stevens Institute of Technology was named as a recipient of the 2010 Young Investigator Program (YIP) award by the Office of Naval Research (ONR). YIP invests in academic scientists and engineers who show exceptional promise... - April 09, 2010 - Stevens Institute of Technology
Silicon Kinetics Announces Addition of Dr. Rick Brown and Dr. Eric Topol to Its Board of Directors
Two new directors bring extensive knowledge and experience in the life sciences industry and academia to the pioneering life sciences tool company. - April 09, 2010 - Silicon Kinetics, Inc.
Early Human Embryos Make "Mistakes" as a Matter of Survival, Could be Key to Understanding Stem Cell Development
Early human embryos may be naturally prone to making mistakes in chromosome allocation to new cells, according to a report by Bedford Stem Cell Research Foundation scientists. Their new findings indicate rapid increases in total genetic information may be more important to embryo survival than... - April 07, 2010 - Bedford Stem Cell Research Foundation
TransEnterix SPIDER® Surgical System Now in Use at Hospitals Across the U.S.
Platform creates new class of minimally invasive surgery called 'Flexible Laparoscopy' - April 07, 2010 - TransEnterix
Gilson Pipetman® Announces the Release of Pipetman M - a New Ergonomic Motorized Pipette from the Manufacturer of the Renowned Original Pipetman
Gilson is proud to announce the release of Pipetman® M, a new family of pipettes and the latest evolution of the Gilson Pipetman®, the world’s pipetting standard for over 35 years. Lightweight and extremely comfortable, Pipetman M is fully motorized and requires virtually zero... - April 04, 2010 - Gilson, Inc.
Singapore Research Institute in International Research Consortium
A*STAR’s ICES is one of the key players in the international scientific community to work on a new and exciting area of research known as formulation science. - April 02, 2010 - Institute of Chemical and Engineering Sciences
Red Cedar Technology’s Design Process Selected for CDC and Gates Foundation Project
HEEDS optimization software used to design new generation of vaccine carriers to help eradicate disease. - March 31, 2010 - Red Cedar Technology
Wockhardt Foundation's Mobile Medical Unit Achieves 50,000 Free Consultations, Screenings, and Treatment of Poor Patients in the First 3 Months of 2010
Wockhardt Foundation a secular not – for – profit organization completed 50,000 medical check ups along with the distribution of free medicines through its 2 Mobile Medical Unit programmes in the first 3 months of 2010. Wockhardt Foundation has already achieved half of last year’s achievement. - March 27, 2010 - Wockhardt Foundation
Radio Frequency (RF) Exposure is Primary Reason for Sleep Quality Decline
Attributing poor sleep quality to 24/7 internet access or stress due to economic woes is a huge misinterpretation of facts. A little known company has built a decade long reputation providing clients the best sleep they’ve had in years despite good or bad economic conditions and regardless of the primary cause for declining sleep quality; uncontrolled proliferation of radiofrequency (RF) emitting wireless and cellular devices at home, school, work and in the environment. - March 25, 2010 - EarthPulse Tech, LLC
International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment from Human Parthenogenetic Stem Cells
International Stem Cell Corporation, an international pioneer and leader in stem cell research, begins its second pre-clinical phase of testing retinal pigment epithelium (RPE) derived from human parthenogenetic stem cells for the treatment of retinal diseases. - March 24, 2010 - International Stem Cell Corporation
U.S. Patent Granted for the Multimeric Adiponectin ELISA
A United States patent has been granted to Sekisui Medical Corp. (Tokyo, Japan), the inventors of the Multimeric Adiponectin ELISA. The Multimeric Adiponectin ELISA is distributed in the U.S. and Canada exclusively by ALPCO Diagnostics. - March 23, 2010 - ALPCO
Affinity Life Science and JSW Life Sciences Ink Strategic Partnership
Affinity Life Sciences, Inc. and JSW Life Sciences have agreed to a Strategic Partnership designed to expand their capabilities and enhance their service offerings. - March 18, 2010 - Affinity Life Sciences
Stevens Hosts ACM Conference on Wireless Network Security March 22-24
The Third Association for Computing Machinery (ACM) Conference on Wireless Network Security (WiSec ’10) will be held on the campus of Stevens Institute of Technology on March 22 - 24, 2010 and now offers the option of single day registration, allowing attendees greater flexibility and the opportunity to visit specific portions of the conference. For a detailed conference program please visit their overview page - http://www.sigsac.org/wisec/WiSec2010/program.html. - March 18, 2010 - Stevens Institute of Technology
Bioo Scientific Launches ELISA to Detect Beta-Lactam Antibiotics in Food
Today Bioo Scientific launched the MaxSignal® Beta-Lactam ELISA Test Kit which detects a broad range of beta-lactam antibiotics in food products. - March 15, 2010 - Bioo Scientific
Perspectives on Ancient Greek Technology
Presented under the auspices of the University Seminars Program of the Alexander S. Onassis Public Benefit Foundation (USA), the Perspectives on Ancient Greek Technology lecture addresses what often seem to be strikingly modern elements of ancient Greek technology. - March 14, 2010 - Stevens Institute of Technology
ITCES to Conduct Study of Weight Loss Drug Product, Obestrin®
ITCES Corporation has been contracted to perform both recruitment and subsequent statistical meta-analysis in a study of the weight loss drug product, Obestrin®. Obestrin® is the commercial name for the combination drug product formerly designated, AVT-12. Obestrin® functions in part... - March 10, 2010 - ITCES Corporation
Claire Ellen Products Introduces Neuroquell, a New Analgesic for Most Types of Pain
Neuroquell, a new, non-prescription analgesic is for a variety of painful acute and chronic neuromusculoskeletal conditions. - March 08, 2010 - Claire Ellen Products
ITCES Renames AVT-12 Weight Loss Combination Drug Product, Obestrin®
After a successful performance in the recently concluded year-long efficacy controlled trial, AVT-12, a combination drug product intended for weight loss, has been redesignated Obestrin® in preparation for the marketplace. The name Obestrin® is particularly appropriate, given the new... - March 07, 2010 - ITCES Corporation
ITCES Corporation Releases Results of Year-Long AVT-12 Weight Loss Controlled Trial
One-year Findings from Controlled Trial of AVT-12 Combination Drug Product on Weight Loss and Various Metabolic Risk Factors - March 06, 2010 - ITCES Corporation
AnaSpec Introduces New Selection of RGD GO™ Peptides
As part of its GO™ Peptides collection, AnaSpec has introduced a selection of cyclic and non-cyclic RGD peptides. - March 05, 2010 - AnaSpec, EGT Group
AVT-12 Weight Loss Drug Product Study Concludes
The weight loss combination drug product, AVT-12 has most recently been the subject of a year-long phase III randomized, double-blind, placebo-controlled efficacy trial, conducted by ITCES Corporation. - March 05, 2010 - ITCES Corporation
AnaSpec Introduces New SensoLyte® 520 Total GSH Quantitation Assay
After the successful launch of its SensoLyte® 520 Thiol Quantitation Assay Kit (patent pending), AnaSpec has released the SensoLyte® 520 Total GSH Assay Kit (patent pending). - March 04, 2010 - AnaSpec, EGT Group
Claire Ellen Products Introduces ProSirona, a New Analgesic for Endometriosis & Fibromyalgia Pain
Claire Ellen Products introduces ProSirona, a new, non-prescription analgesic for endometriosis & fibromyalgia pain. March is Endometriosis Awareness Month—this terrible condition affects the lives of 6.3 million women and girls in the U.S., and 89 million worldwide. - March 04, 2010 - Claire Ellen Products
Congenix Adds Russian Presence to Health Decisions’ Agile Clinical Network
CRO based in Moscow joins Health Decisions’ worldwide network of research organizations dedicated to maximizing the efficiency of global trials - March 04, 2010 - Health Decisions
ITCES Innovator of the Year Award Presented
The ITCES Innovator of the Year Award 2009 has been presented to Dr. David Klein for his recent work in unified algorithmic theory. ITCES Director, Thomas Schwartz made the award presentation. “It is my honor to present the 2009 ITCES Innovator of the Year Award to Dr. David Klein. Our... - March 03, 2010 - ITCES Corporation
Stevens Institute of Technology Students are Finalists in CIMIT Competition
A multi-disciplinary team of Electrical, Computer and Biomedical Engineering seniors at Stevens Institute of Technology are finalists in the 2010 CIMIT Prize for Primary Healthcare Competition. Pete Backeris, dual major and team member, coordinated the BME and ECE teams to submit a proposal for the Digital Triage Assistant (DTA) project to the Center for Integration of Medicine & Innovative Technology (CIMIT) prize competition. - March 01, 2010 - Stevens Institute of Technology
Translational Regenerative Medicine Event to Feature Venture Forum
A spray-on skin product and an injectable cell therapy for heart attack patients are among 17 regenerative medicine technologies that will be showcased during the Translational Regenerative Medicine Forum, set for April 6-8 in Winston-Salem, N.C. Representatives from 17 startup biotech companies... - March 01, 2010 - Regenerative Medicine Foundation
AnaSpec Introduces New MESA qPCR Mastermixes
AnaSpec is pleased to announce the availability of new MESA FAST and BLUE qPCR Mastermixes as part of its growing product catalog. - February 28, 2010 - AnaSpec, EGT Group
AnaSpec Collects Food for Alameda County Community Food Bank
AnaSpec is pleased to announce that AnaSpec employees collected ninety pounds of food. - February 26, 2010 - AnaSpec, EGT Group
Dr. Yingying Chen Receives Prestigious NSF CAREER Award
Dr. Yingying Chen of the Department of Electrical & Computer Engineering at Stevens Institute of Technology was recently given The National Science Foundation’s highly competitive peer accolade, the Faculty Early Career Development (CAREER) Award for her research, “Enhancing the Security of Pervasive Wireless Networks by Exploiting Location.” This funding is part of a continuing grant which goes into effect on March 1st, 2010. - February 26, 2010 - Stevens Institute of Technology
Clinical Trials in Russia. Year 2009
On February 24, 2010 Synergy Research Group (SynRG), a Russia-based CRO, presented the Russian version of SynRG Orange Paper 2009, the annual analytical report on the clinical trial market in Russia. The full report will be presented at the DIA EuroMeeting in Monaco during 8-10 March 2010, and will be available at SynRG booth No. 5. - February 25, 2010 - Synergy Research Group
New White Paper Reports the Five Essentials for Minimizing Clinical Development Risk
CRO Health Decisions explains how a systematic risk mitigation system can prevent undue FDA rejection - February 20, 2010 - Health Decisions
Speed New Drug and Medical Device Time to Market with Advice in New Book by Cerulean's Managing Director
FDA compliance guru, John Avellanet, shows biopharmaceutical and device executives how to speed time to market with new medicines and turn regulatory compliance into a competitive business advantage in his new book, Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine. - February 19, 2010 - Cerulean Associates LLC
National Institute of Mental Health Awards a Phase I SBIR Grant to MicroTransponder to Develop a Neurostimulation-based Therapy to Treat Post Traumatic Stress Disorder
MicroTransponder, Inc., a privately-held medical device company, announced that it has been awarded a Phase I SBIR grant from the National Institute of Mental Health (NIMH) to develop a neurostimulation-based therapy for the treatment of Post Traumatic Stress Disorder (PTSD). This project will... - February 19, 2010 - MicroTransponder Inc.
Botanical Wisdom Releases: Rapid Cell Infusion
Botanical Wisdom releases their line of Rapid Cell Infusion which contains 25 new products. These 25 new products promote a healthier lifestyle and are all made with their faster acting Bio-Enhanced Extraction Process. - February 19, 2010 - Botanical Wisdom
Dr. Alan Blumberg Featured on National Geographic February 18, 10PM
This Thursday, February 18th at 10PM EST, Dr. Alan Blumberg of Stevens Institute of Technology will participate in the National Geographic Channel Program entitled “Naked Science.” The program chronicles scientific investigations into several of the biggest mysteries of our time. It is... - February 18, 2010 - Stevens Institute of Technology
Institute for Integrated Healthcare Appointed as Pharmacy Advisor to MidAtlantic Business Group on Health
Pharmaceuticals-Related Benefits Consultancy Will Maximize Pharmaceutical Value for Business Coalition Members - February 17, 2010 - Institute for Integrated Healthcare
AnaSpec’s Published References Pass 900
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 900. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - February 12, 2010 - AnaSpec, EGT Group
AnaSpec Introduces New SensoLyte® Anti-PLP Assay Kits
AnaSpec, has announced the release of two new multiple sclerosis (MS)/experimental autoimmune encephalomyelitis (EAE) related ELISA assays kits, the SensoLyte® Anti-PLP(139-151) Assay Kit and the SensoLyte® Anti-PLP(178-191) Assay Kit. - February 11, 2010 - AnaSpec, EGT Group
Silicon Kinetics Announces New Biosensor Chips with Wide Palette of Surface Chemistries
The world's first 3D biosensor surface for label-free biomolecular interaction analysis now offers surface chemistries for: carboxyl, streptavidin, benzaldehyde, NTA-Ni for His-tagged proteins, Protein A and Protein G for coupling antibodies. - February 08, 2010 - Silicon Kinetics, Inc.
Bioo Scientific Facilitates Rapid Screening of Gluten, Egg Powder and Poultry for Melamine
Bioo Scientific’s MaxSignal® Melamine Enzymatic Assay has validated sample prep procedures for the rapid screening of whole egg powder, poultry meat, wheat gluten, pig feed and chicken feed for melamine contamination. - February 08, 2010 - Bioo Scientific
Baxa Corporation to Sponsor Customer-Requested DoseEdge™ Product Demonstrations Following Successful ASHP Midyear Clinical Meeting
Baxa Corporation announces dates for a nine-city road show tour featuring the DoseEdge Pharmacy Workflow Manager. A related March Webinar is scheduled for customers who are unable to attend the live product demonstration programs. - February 05, 2010 - Baxa Corporation